Milan, Italy

Andrea Annoni

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrea Annoni: Innovator in Gene Therapy

Introduction

Andrea Annoni is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of gene therapy, particularly in the development of viral vectors for medical applications. With a total of 2 patents, her work is paving the way for advancements in treating various diseases.

Latest Patents

Andrea's latest patents include innovative technologies that enhance the production and efficacy of gene vectors. One of her patents focuses on virus vector production, specifically an enveloped viral particle producer or packaging cell. This cell is genetically engineered to decrease the expression of CD47 on its surface, which is crucial for improving the effectiveness of gene therapies. Another notable patent is a gene vector designed for inducing transgene-specific immune tolerance. This gene vector is adapted for transient expression of a transgene in peripheral organ cells, featuring a regulatory sequence that prevents or reduces expression in hematopoietic lineage cells.

Career Highlights

Throughout her career, Andrea has worked with esteemed organizations such as Ospedale San Raffaele S.r.l. and Fondazione Telethon Ets. Her experience in these institutions has allowed her to collaborate on groundbreaking research and contribute to the advancement of gene therapy techniques.

Collaborations

Andrea has collaborated with notable colleagues in her field, including Alessio Cantore and Luigi Naldini. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Andrea Annoni is a trailblazer in the field of gene therapy, with her patents and collaborations significantly impacting medical research. Her work continues to inspire future innovations in the treatment of genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…